|
CONSULTING AGREEMENTS (Details Textual) (USD $)
In Thousands, except Share data, unless otherwise specified |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | 144 Months Ended | 9 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 31, 2012
|
Apr. 30, 2012
|
Jun. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Dec. 31, 2010
|
Dec. 31, 2004
|
Sep. 30, 2012
|
Sep. 30, 2012
Common Stock [Member]
|
Dec. 31, 2010
Common Stock [Member]
|
Dec. 31, 2011
Prof Eldad Melamed [Member]
|
Dec. 31, 2004
Prof Eldad Melamed [Member]
|
Jun. 30, 2012
Dr Daniel Offen [Member]
|
Dec. 31, 2004
Dr Daniel Offen [Member]
|
Jun. 30, 2012
Dr Daniel Offen [Member]
Common Stock [Member]
|
Jun. 30, 2012
Dr Daniel Offen [Member]
Cash [Member]
|
Sep. 30, 2012
Consultants [Member]
|
Dec. 31, 2010
Consultants [Member]
|
||||
| Monthly Payment Of Consulting Fees | $ 6 | $ 6 | |||||||||||||||||||||
| Warrants Issued To Purchase Of Common Stock | 33,334 | 1,097,215 | |||||||||||||||||||||
| Investment Warrants, Exercise Price | $ 0.348 | $ 0.01 | |||||||||||||||||||||
| Deferred Compensation Arrangement With Individual, Maximum Contractual Term | seven year | ||||||||||||||||||||||
| Stock Issued During Period, Shares, New Issues | 476,666 | 19,818,968 | 2,475,000 | 400,000 | 623,077 | 1,100,000 | |||||||||||||||||
| Consultant Charges Cancelled | 487 | ||||||||||||||||||||||
| Consultant Charges Payable | 27 | 27 | 27 | ||||||||||||||||||||
| Consulting Expenses Monthly Payment | 6 | 3 | 3 | ||||||||||||||||||||
| Deferred Compensation Arrangement with Individual, Compensation Expense | 192 | 162 | |||||||||||||||||||||
| Research and development, net | $ 732 | $ 176 | $ 1,486 | $ 1,032 | $ 25,905 | [1] | $ 220 | ||||||||||||||||
|
|||||||||||||||||||||||